Starwood European Real Estate Finance Limited News - SWEF

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger

MISSISSAUGA, ON, Oct. 19 /PRNewswire-FirstCall/ -- Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) and IntelliPharmaCeutics Ltd. ("IPC") are pleased to...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Vasogen Announces Third Quarter 2009 Results

MISSISSAUGA, ON, Oct. 15 /PRNewswire-FirstCall/ -- Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today reported the results of operations for the three...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company

Vasogen to also Raise $7.5 Million in Non-Dilutive Financing from Cervus LP MISSISSAUGA, ON, Aug. 17 /PRNewswire-FirstCall/ -- Vasogen Inc...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

- Report of Foreign Issuer (6-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF...

Vasogen Announces Second Quarter 2009 Results

MISSISSAUGA, ON, July 14 /PRNewswire-FirstCall/ -- Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today reported the results of operations for the three...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Starwood European Real Estate Finance Limited (SWEF)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

SWEF News

- Report of Foreign Issuer (6-K)

Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

Vasogen Announces Third Quarter 2009 Results

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

Vasogen Announces Second Quarter 2009 Results

SWEF Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Starwood European Real Estate Finance Limited (SWEF) News

Starwood European Real Estate Finance Limited (SWEF)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

SWEF News

- Report of Foreign Issuer (6-K)

Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

Vasogen Announces Third Quarter 2009 Results

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

Vasogen and IntelliPharmaCeutics to Combine to Create Publicly-traded Specialty Pharmaceutical Company

- Report of Foreign Issuer (6-K)

- Report of Foreign Issuer (6-K)

Vasogen Announces Second Quarter 2009 Results

SWEF Discussion

Your Recent History